Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for RPL.DE and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RPL.DE and 80,000+ other tickers.
See exactly how RPL.DE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RPL.DE and 80,000+ other tickers.
UPM-Kymmene Oyj is a prominent player in the forest-based bioindustry sector. Its diverse operations are organized into key segments: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers, UPM Plywood, and various other activities. The company's offerings include a range of pulp types, such as softwood, birch, and eucalyptus, which are essential for producing tissue, specialized, and graphic papers, as well as packaging solutions. It also manufactures sawn timber, catering to the joinery, packaging, furniture, planning, and construction industries…
No recent news available.